Nutex Health (NASDAQ:NUTX) Hits New 52-Week High – Time to Buy?

Nutex Health Inc. (NASDAQ:NUTX)’s share price hit a new 52-week high during trading on Monday . The company traded as high as $204.06 and last traded at $206.8640, with a volume of 11840 shares. The stock had previously closed at $195.20.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on NUTX. Wall Street Zen cut shares of Nutex Health from a “buy” rating to a “hold” rating in a report on Saturday, September 5th. Lake Street Capital reiterated a “buy” rating and set a $310.00 price objective (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. Weiss Ratings raised shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, July 28th. B. Riley Financial raised their target price on shares of Nutex Health from $290.00 to $325.00 and gave the company a “buy” rating in a research note on Friday, September 4th. Finally, Zacks Research raised Nutex Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, August 24th. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $317.50.

Nutex Health Stock Performance

The company has a market capitalization of $1.48 billion, a PE ratio of 8.45 and a beta of 0.28. The firm has a 50-day moving average of $177.71 and a two-hundred day moving average of $141.87. The company has a quick ratio of 4.96, a current ratio of 5.00 and a debt-to-equity ratio of 0.59.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings data on Thursday, August 6th. The company reported $9.38 EPS for the quarter, topping analysts’ consensus estimates of $4.95 by $4.43. Nutex Health had a net margin of 21.25% and a return on equity of 39.74%. The business had revenue of $210.75 million for the quarter, compared to analysts’ expectations of $215.03 million. Research analysts anticipate that Nutex Health Inc. will post 27.58 EPS for the current year.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of NUTX. BlackRock Inc. acquired a new stake in Nutex Health in the second quarter valued at approximately $69,612,000. Winmill & CO. Inc. acquired a new position in shares of Nutex Health during the 2nd quarter worth approximately $11,168,000. Empowered Funds LLC acquired a new position in shares of Nutex Health during the 2nd quarter worth approximately $7,720,000. SG Americas Securities LLC lifted its position in shares of Nutex Health by 3,232.6% during the 1st quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock valued at $2,885,000 after buying an additional 29,449 shares in the last quarter. Finally, Bank of New York Mellon Corp purchased a new position in shares of Nutex Health during the 2nd quarter valued at approximately $3,956,000. Institutional investors and hedge funds own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health Inc (NASDAQ:NUTX) is a physician-led healthcare services company that operates an integrated network of hospitals, outpatient facilities and physician practices. The company focuses on delivering emergency, inpatient and outpatient care through community-based healthcare facilities, including micro-hospitals designed to provide essential hospital services in convenient local settings.

Its services may include emergency medicine, primary care, specialty care, diagnostic testing, imaging, laboratory services and other ancillary healthcare offerings.